| Msg 73156 of 73993 at 6/11/2012 10:33:02 AM by |
|
|
IMS Scrip Data last 12 weeks -Memorial Day Monday May 28
|
Byetta |
|
Amylin |
|
|
|
|
Trx |
Nrx |
Trx % ch |
Nrx % ch |
Rrx |
Rrx % ch |
| 16-Mar-12 |
25,697 |
9,912 |
(5.30%) |
(3.08%) |
15,785 |
(6.65%) |
| 23-Mar-12 |
25,077 |
9,444 |
(2.41%) |
(4.72%) |
15,633 |
(0.96%) |
| 30-Mar-12 |
26,683 |
9,845 |
6.40% |
4.25% |
16,838 |
7.71% |
| 6-Apr-12 |
26,718 |
9,566 |
0.13% |
(2.83%) |
17,152 |
1.86% |
| 13-Apr-12 |
24,387 |
8,998 |
(8.72%) |
(5.94%) |
15,389 |
(10.28%) |
| 20-Apr-12 |
24,828 |
9,100 |
1.81% |
1.13% |
15,728 |
2.20% |
| 27-Apr-12 |
25,252 |
9,391 |
1.71% |
3.20% |
15,861 |
0.85% |
| 4-May-12 |
26,758 |
9,638 |
5.96% |
2.63% |
17,120 |
7.94% |
| 11-May-12 |
25,065 |
9,314 |
(6.33%) |
(3.36%) |
15,751 |
(8.00%) |
| 18-May-12 |
24,234 |
8,800 |
(3.32%) |
(5.52%) |
15,434 |
(2.01%) |
| 25-May-12 |
24,568 |
9,011 |
1.38% |
2.40% |
15,557 |
0.80% |
| 1-Jun-12 |
24,129 |
8,241 |
(1.79%) |
(8.55%) |
15,888 |
2.13% |
|
Bydureon |
|
Amylin |
|
|
|
|
Trx |
Nrx |
Trx % ch |
Nrx % ch |
Rrx |
Rrx % ch |
| 16-Mar-12 |
1,947 |
1,828 |
18.79% |
13.54% |
119 |
310.34% |
| 23-Mar-12 |
2,565 |
2,261 |
31.74% |
23.69% |
304 |
155.46% |
| 30-Mar-12 |
2,884 |
2,469 |
12.44% |
9.20% |
415 |
36.51% |
| 6-Apr-12 |
3,182 |
2,603 |
10.33% |
5.43% |
579 |
39.52% |
| 13-Apr-12 |
3,781 |
2,934 |
18.82% |
12.72% |
847 |
46.29% |
| 20-Apr-12 |
3,967 |
2,885 |
4.92% |
(1.67%) |
1,082 |
27.74% |
| 27-Apr-12 |
4,480 |
3,116 |
12.93% |
8.01% |
1,364 |
26.06% |
| 4-May-12 |
4,779 |
3,197 |
6.67% |
2.60% |
1,582 |
15.98% |
| 11-May-12 |
4,798 |
3,055 |
0.40% |
(4.44%) |
1,743 |
10.18% |
| 18-May-12 |
5,402 |
3,385 |
12.59% |
10.80% |
2,017 |
15.72% |
| 25-May-12 |
5,639 |
3,413 |
4.39% |
0.83% |
2,226 |
10.36% |
| 1-Jun-12 |
5,204 |
2,795 |
(7.71%) |
(18.11%) |
2,409 |
8.22% |
| |
Victoza for Diabetes |
Novo Nordisk |
|
|
| |
Trx |
Nrx |
Trx % ch |
Nrx % ch |
Rrx |
Rrx % ch |
| 16-Mar-12 |
36,149 |
14,687 |
(1.11%) |
(3.23%) |
21,462 |
0.40% |
| 23-Mar-12 |
35,720 |
14,545 |
(1.19%) |
(0.97%) |
21,175 |
(1.34%) |
| 30-Mar-12 |
37,143 |
14,885 |
3.98% |
2.34% |
22,258 |
5.11% |
| 6-Apr-12 |
37,091 |
14,676 |
(0.14%) |
(1.40%) |
22,415 |
0.71% |
| 13-Apr-12 |
36,028 |
14,336 |
(2.87%) |
(2.32%) |
21,692 |
(3.23%) |
| 20-Apr-12 |
37,234 |
14,974 |
3.35% |
4.45% |
22,260 |
2.62% |
| 27-Apr-12 |
37,467 |
14,957 |
0.63% |
(0.11%) |
22,510 |
1.12% |
| 4-May-12 |
39,120 |
15,419 |
4.41% |
3.09% |
23,701 |
5.29% |
| 11-May-12 |
38,203 |
15,279 |
(2.34%) |
(0.91%) |
22,924 |
(3.28%) |
| 18-May-12 |
38,822 |
15,485 |
1.62% |
1.35% |
23,337 |
1.80% |
| 25-May-12 |
39,147 |
15,703 |
0.84% |
1.41% |
23,444 |
0.46% |
| 1-Jun-12 |
37,442 |
14,320 |
(4.36%) |
(8.81%) |
23,122 |
(1.37%) |
|
Symlin |
|
Amylin |
|
|
|
|
Trx |
Nrx |
Trx % ch |
Nrx % ch |
Rrx |
Rrx % ch |
| 16-Mar-12 |
2,752 |
1,160 |
(1.57%) |
2.11% |
1,592 |
(4.10%) |
| 23-Mar-12 |
2,708 |
1,169 |
(1.60%) |
0.78% |
1,539 |
(3.33%) |
| 30-Mar-12 |
2,852 |
1,250 |
5.32% |
6.93% |
1,602 |
4.09% |
| 6-Apr-12 |
2,789 |
1,115 |
(2.21%) |
(10.80%) |
1,674 |
4.49% |
| 13-Apr-12 |
2,556 |
1,063 |
(8.35%) |
(4.66%) |
1,493 |
(10.81%) |
| 20-Apr-12 |
2,503 |
1,069 |
(2.07%) |
0.56% |
1,434 |
(3.95%) |
| 27-Apr-12 |
2,612 |
1,118 |
4.35% |
4.58% |
1,494 |
4.18% |
| 4-May-12 |
2,909 |
1,235 |
11.37% |
10.47% |
1,674 |
12.05% |
| 11-May-12 |
2,490 |
1,063 |
(14.40%) |
(13.93%) |
1,427 |
(14.76%) |
| 18-May-12 |
2,614 |
1,098 |
4.98% |
3.29% |
1,516 |
6.24% |
| 25-May-12 |
2,541 |
1,120 |
(2.79%) |
2.00% |
1,421 |
(6.27%) |
| 1-Jun-12 |
2,484 |
934 |
(2.24%) |
(16.61%) |
1,550 |
9.08% |
|
Lantus |
|
Sanofi-Aventis |
|
|
|
Trx |
Nrx |
Trx % ch |
Nrx % ch |
Rrx |
Rrx % ch |
| 16-Mar-12 |
192,644 |
73,504 |
(5.94%) |
(5.71%) |
119,140 |
(6.09%) |
| 23-Mar-12 |
191,765 |
73,488 |
(0.46%) |
(0.02%) |
118,277 |
(0.72%) |
| 30-Mar-12 |
194,625 |
73,218 |
1.49% |
(0.37%) |
121,407 |
2.65% |
| 6-Apr-12 |
206,539 |
76,248 |
6.12% |
4.14% |
130,291 |
7.32% |
| 13-Apr-12 |
191,941 |
72,009 |
(7.07%) |
(5.56%) |
119,932 |
(7.95%) |
| 20-Apr-12 |
189,349 |
71,788 |
(1.35%) |
(0.31%) |
117,561 |
(1.98%) |
| 27-Apr-12 |
191,857 |
72,256 |
1.32% |
0.65% |
119,601 |
1.74% |
| 4-May-12 |
208,134 |
75,707 |
8.48% |
4.78% |
132,427 |
10.72% |
| 11-May-12 |
194,944 |
72,970 |
(6.34%) |
(3.62%) |
121,974 |
(7.89%) |
| 18-May-12 |
189,268 |
70,546 |
(2.91%) |
(3.32%) |
118,722 |
(2.67%) |
| 25-May-12 |
190,893 |
71,255 |
0.86% |
1.01% |
119,638 |
0.77% |
| 1-Jun-12 |
189,125 |
66,933 |
(0.93%) |
(6.07%) |
122,192 |
2.13% |
|
Januvia DPP-4 |
Merck |
|
|
|
|
Trx |
Nrx |
Trx % ch |
Nrx % ch |
Rrx |
Rrx % ch |
| 16-Mar-12 |
164,643 |
59,631 |
(4.18%) |
(2.76%) |
105,012 |
(4.98%) |
| 23-Mar-12 |
160,507 |
57,867 |
(2.51%) |
(2.96%) |
102,640 |
(2.26%) |
| 30-Mar-12 |
167,881 |
59,632 |
4.59% |
3.05% |
108,249 |
5.46% |
| 6-Apr-12 |
177,241 |
60,700 |
5.58% |
1.79% |
116,541 |
7.66% |
| 13-Apr-12 |
166,592 |
58,415 |
(6.01%) |
(3.76%) |
108,177 |
(7.18%) |
| 20-Apr-12 |
164,506 |
57,817 |
(1.25%) |
(1.02%) |
106,689 |
(1.38%) |
| 27-Apr-12 |
166,893 |
58,669 |
1.45% |
1.47% |
108,224 |
1.44% |
| 4-May-12 |
179,527 |
61,504 |
7.57% |
4.83% |
118,023 |
9.05% |
| 11-May-12 |
168,551 |
58,856 |
(6.11%) |
(4.31%) |
109,695 |
(7.06%) |
| 18-May-12 |
167,236 |
57,598 |
(0.78%) |
(2.14%) |
109,638 |
(0.05%) |
| 25-May-12 |
165,390 |
57,267 |
(1.10%) |
(0.57%) |
108,123 |
(1.38%) |
| 1-Jun-12 |
163,920 |
53,014 |
(0.89%) |
(7.43%) |
110,906 |
2.57% |
|
Onglyza Type II Diabetes
DPP-4 |
Bristol MyersSquibb |
|
|
Trx |
Nrx |
Trx % ch |
Nrx % ch |
Rrx |
Rrx % ch |
| 16-Mar-12 |
33,127 |
12,057 |
(4.15%) |
(2.88%) |
21,070 |
(4.86%) |
| 23-Mar-12 |
32,518 |
11,784 |
(1.84%) |
(2.26%) |
20,734 |
(1.59%) |
| 30-Mar-12 |
33,299 |
12,086 |
2.40% |
2.56% |
21,213 |
2.31% |
| 6-Apr-12 |
35,235 |
12,275 |
5.81% |
1.56% |
22,960 |
8.24% |
| 13-Apr-12 |
33,218 |
11,934 |
(5.72%) |
(2.78%) |
21,284 |
(7.30%) |
| 20-Apr-12 |
33,071 |
11,770 |
(0.44%) |
(1.37%) |
21,301 |
0.08% |
| 27-Apr-12 |
33,538 |
12,195 |
1.41% |
3.61% |
21,343 |
0.20% |
| 4-May-12 |
36,260 |
12,710 |
8.12% |
4.22% |
23,550 |
10.34% |
| 11-May-12 |
34,696 |
12,516 |
(4.31%) |
(1.53%) |
22,180 |
(5.82%) |
| 18-May-12 |
33,889 |
12,232 |
(2.33%) |
(2.27%) |
21,657 |
(2.36%) |
| 25-May-12 |
34,081 |
12,352 |
0.57% |
0.98% |
21,729 |
0.33% |
| 1-Jun-12 |
33,360 |
11,205 |
(2.12%) |
(9.29%) |
22,155 |
1.96% |
|
|
